Seres Therapeutics (MCRB) Shares Outstanding (2014 - 2026)

Seres Therapeutics has reported Shares Outstanding (Entity) for 13 years, with the latest figure at $9.6 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 9.85% year-over-year to $9.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.6 million (up 9.85% YoY) and the FY2025 annual result came in at $9.6 million, up 10.48% from the prior year.
• Shares Outstanding (Entity) was little changed at $9.6 million in Q1 2026 per MCRB's latest filing, from $9.6 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $9.6 million in Q1 2026 and troughed at $4.6 million in Q1 2022.
• A 5-year average of $7.4 million and a median of $7.6 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) grew 0.65% in 2022, then soared 38.71% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $6.3 million in 2022, then grew by 7.84% to $6.8 million in 2023, then advanced by 28.11% to $8.7 million in 2024, then rose by 10.48% to $9.6 million in 2025, then gained by 0.38% to $9.6 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $9.6 million, $9.6 million, and $8.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.